Craniotomy versus Endoscopic Membranectomy in the Treatment of Non-Homogeneous Chronic Subdural Hematoma: A Pilot Randomized Parallel-Group Active-Controlled Trial (EMiT CSDH 2).

IF 0.8 3区 医学 Q4 NEUROSCIENCES
Neurology India Pub Date : 2026-09-01 Epub Date: 2026-08-19 DOI:10.4103/neurol-india.Neurol-India-D-25-00844
K P Priyadharshan, M Kodeeswaran, S Prasad
{"title":"Craniotomy versus Endoscopic Membranectomy in the Treatment of Non-Homogeneous Chronic Subdural Hematoma: A Pilot Randomized Parallel-Group Active-Controlled Trial (EMiT CSDH 2).","authors":"K P Priyadharshan, M Kodeeswaran, S Prasad","doi":"10.4103/neurol-india.Neurol-India-D-25-00844","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic subdural hematoma (CSDH) is a prevalent neurosurgical condition with persistent challenges related to recurrence. Endoscopic membranectomy (EM) has shown promising results in managing symptomatic non-homogenous (SNH)-CSDH, but comparative evidence against craniotomy with membranectomy (CM) is lacking.</p><p><strong>Objectives: </strong>To compare the safety and efficacy of EM versus CM in managing SNH-CSDH.</p><p><strong>Materials and methods: </strong>A pilot randomized parallel-group active-controlled open- labeled superiority trial from September 2023 to November 2024 at Government Kilpauk Medical College, Chennai, India. Sixty patients with SNH-CSDH were randomized into EM and CM groups. Recurrence was the primary outcome. Secondary outcomes included operative time, complications, radiological indices, pain, hospital stay, and functional recovery. All patients were followed for six months.</p><p><strong>Results: </strong>No recurrence was observed in either group at six months. Two CM patients required reoperation on postoperative day one ( P = 0.15). EM was associated with shorter operative time ( P = 0.02), lower incidence of post-operative subdural residual fluid ( P = 0.015), better early hematoma reduction/subdural space reduction index ( P = 0.008), midline shift/symmetry improvement index ( P = 0.001), and lesser surgical site swelling ( P < 0.001). All patients were ambulant and had a Glasgow coma scale (GCS) 15 at discharge and at six months (including reoperated patients). Pain scores and functional recovery were comparable. EM patients had shorter hospital stays ( P = 0.004) and no significant complications.</p><p><strong>Conclusion: </strong>EM demonstrated favorable early radiological outcomes, fewer complications, and comparable functional recovery and recurrence versus CM in SNH-CSDH. Independent reproduction and larger multicentric trials are needed for validity and generalizability.</p>","PeriodicalId":19429,"journal":{"name":"Neurology India","volume":" ","pages":"844-852"},"PeriodicalIF":0.8000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology India","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/neurol-india.Neurol-India-D-25-00844","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/19 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic subdural hematoma (CSDH) is a prevalent neurosurgical condition with persistent challenges related to recurrence. Endoscopic membranectomy (EM) has shown promising results in managing symptomatic non-homogenous (SNH)-CSDH, but comparative evidence against craniotomy with membranectomy (CM) is lacking.

Objectives: To compare the safety and efficacy of EM versus CM in managing SNH-CSDH.

Materials and methods: A pilot randomized parallel-group active-controlled open- labeled superiority trial from September 2023 to November 2024 at Government Kilpauk Medical College, Chennai, India. Sixty patients with SNH-CSDH were randomized into EM and CM groups. Recurrence was the primary outcome. Secondary outcomes included operative time, complications, radiological indices, pain, hospital stay, and functional recovery. All patients were followed for six months.

Results: No recurrence was observed in either group at six months. Two CM patients required reoperation on postoperative day one ( P = 0.15). EM was associated with shorter operative time ( P = 0.02), lower incidence of post-operative subdural residual fluid ( P = 0.015), better early hematoma reduction/subdural space reduction index ( P = 0.008), midline shift/symmetry improvement index ( P = 0.001), and lesser surgical site swelling ( P < 0.001). All patients were ambulant and had a Glasgow coma scale (GCS) 15 at discharge and at six months (including reoperated patients). Pain scores and functional recovery were comparable. EM patients had shorter hospital stays ( P = 0.004) and no significant complications.

Conclusion: EM demonstrated favorable early radiological outcomes, fewer complications, and comparable functional recovery and recurrence versus CM in SNH-CSDH. Independent reproduction and larger multicentric trials are needed for validity and generalizability.

开颅与内镜膜切除术治疗非均质慢性硬膜下血肿:一项随机平行组主动对照试验(EMiT CSDH 2)。
背景:慢性硬膜下血肿(CSDH)是一种常见的神经外科疾病,与复发相关的持续挑战。内镜下膜切除术(EM)在治疗症状性非均质性(SNH)-CSDH方面显示出有希望的结果,但相对于开颅与膜切除术(CM)的比较证据缺乏。目的:比较EM与CM治疗SNH-CSDH的安全性和有效性。材料和方法:2023年9月至2024年11月在印度金奈政府基尔帕克医学院进行的一项随机平行组主动对照开放标签优势试验。60例SNH-CSDH患者随机分为EM组和CM组。复发是主要结局。次要结局包括手术时间、并发症、放射学指标、疼痛、住院时间和功能恢复。所有患者随访6个月。结果:两组患者6个月无复发。2例CM患者术后第1天再次手术(P = 0.15)。EM与较短的手术时间(P = 0.02)、较低的术后硬膜下积液发生率(P = 0.015)、较好的早期血肿减少/硬膜下间隙缩小指数(P = 0.008)、中线移位/对称性改善指数(P = 0.001)、较小的手术部位肿胀(P < 0.001)相关。所有患者均可走动,出院时和6个月时格拉斯哥昏迷评分(GCS)为15分(包括再手术患者)。疼痛评分和功能恢复具有可比性。EM患者住院时间较短(P = 0.004),无明显并发症。结论:与CM相比,EM在SNH-CSDH中表现出良好的早期放射学结果,并发症较少,功能恢复和复发率相当。需要独立的重复和更大的多中心试验来验证有效性和可推广性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology India
Neurology India 医学-神经科学
CiteScore
1.60
自引率
70.40%
发文量
434
审稿时长
2 months
期刊介绍: Neurology India (ISSN 0028-3886) is Bi-monthly publication of Neurological Society of India. Neurology India, the show window of the progress of Neurological Sciences in India, has successfully completed 50 years of publication in the year 2002. ‘Neurology India’, along with the Neurological Society of India, has grown stronger with the passing of every year. The full articles of the journal are now available on internet with more than 20000 visitors in a month and the journal is indexed in MEDLINE and Index Medicus, Current Contents, Neuroscience Citation Index and EMBASE in addition to 10 other indexing avenues. This specialty journal reaches to about 2000 neurologists, neurosurgeons, neuro-psychiatrists, and others working in the fields of neurology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书